Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Pharma continues to invest in UK research and development

October 24, 2005 Sales and Marketing Pfizer, R&D

 UK pharma and biotech companies increased R&D investment by 4% in the last year, according to the latest government figures.The …
News

Vaccine companies to compete for UK pandemic contract

October 20, 2005 Sales and Marketing

Vaccine companies are to compete with each other to produce a vaccine against a potential pandemic flu – although no-one …
News

New approvals in TNF-blocker class

October 20, 2005 Sales and Marketing

Competition in one of the industry's fastest growing markets is intensifying with new approvals for two TNF-blocker drugs.Schering-Plough and Centocor's …
News

Once a day pill promises period-free contraception

October 20, 2005 Sales and Marketing

The world's first-ever contraceptive pill to offer women complete freedom from menstruation could be launched by next year.Wyeth's Lybrel is …
News

Tarceva/Avastin combination disappoints in kidney cancer

October 19, 2005 Sales and Marketing

Early results from trials suggest adding Tarceva to Avastin has no extra benefit in the treatment of kidney cancer.Researchers at …
News

Exubera recommended by European regulator

October 18, 2005 Sales and Marketing

Exubera, the first ever inhaled insulin product is set for approval in Europe following a key regulatory recommendation.The positive opinion …
News

Pfizer wins UK Lipitor court battle

October 14, 2005 Sales and Marketing

Pfizer has won an important legal battle to maintain its UK patent on best-selling cholesterol drug Lipitor.The UK High Court …
News

Sanofi-Aventis launch new short-acting insulin competitor Apidra

October 13, 2005 Sales and Marketing

Apidra, a new short-acting insulin analogue, has been launched in the UK by Sanofi-Aventis.Short-acting analogues have a faster onset of …
News

EMEA reforms to speed drug approval

October 13, 2005 Sales and Marketing

Europe's medicines regulator is looking to communicate more effectively with pharma companies as part of a drive to accelerate drug …
News

Merck looks to rebuild reputation one year on from Vioxx

October 13, 2005 Sales and Marketing

Merck looks set to launch a new public relations campaign across Europe in an attempt to repair damage done to …
News

VNU shareholders rebel over IMS bid

October 13, 2005 Sales and Marketing

A significant minority of shareholders in VNU are against its planned $7 billion acquisition of pharmaceutical information company IMS Health.The …
News

Reducing POM to P headaches

October 12, 2005 Sales and Marketing

Following an eight-week period of public consultation, the Committee on Safety of Medicines is to shortly advise health ministers about …
Feature

Pharma cast as ‘bad guys’ in Hollywood blockbuster

September 30, 2005 Sales and Marketing

A new Hollywood thriller featuring the pharmaceutical industry as the 'bad guys' is to hit UK screens next week.The Constant …
News

Davis to leave Takeda UK

September 30, 2005 Sales and Marketing

Andy Davis, the high-profile managing director of Takeda UK is to leave the company.Davis is best known for overseeing a …
News

New leader for FDA in turmoil

September 30, 2005 Sales and Marketing

Andrew von Eschenbach has been appointed the new acting head of the FDA after the surprise resignation of Lester Crawford.Crawford …
News
The Gateway to Local Adoption Series

Latest content

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026